Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Excursion to Different Universes: the Top Sci-fi Motion pictures Ever - 2Egypt's cafés and shops forced to close early due to Iran war
- 3Instructions to Pick the Ideal SUV Size for Seniors
- 4Israel has clear objectives south of Litani River, but will face difficult choices further north
- 5NASA troubleshoots Artemis II toilet problem in otherwise smooth flight
- Examination In progress into Abuse of Japanese Government-Supported Advance
- Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- This Tiny Bright Yellow Frog Is One of the Most Toxic Animals on Earth
- Canada's Friendly Sunshine Coast City Is An Outdoor Playground Perfect For Hiking And Paddling
- The Solution to Flexibility: Developing Internal Fortitude Notwithstanding Misfortune
- South Carolina measles outbreak grows by nearly 100, spreads to North Carolina and Ohio
- 6 Famous Cell phone Brands All over The Planet
- Study reveals links between global food systems, obesity, and climate change
- A Manual for Extravagant Vehicles Available in 2024
